JPS6034905A - 肺表面活性物質製剤 - Google Patents
肺表面活性物質製剤Info
- Publication number
- JPS6034905A JPS6034905A JP58142520A JP14252083A JPS6034905A JP S6034905 A JPS6034905 A JP S6034905A JP 58142520 A JP58142520 A JP 58142520A JP 14252083 A JP14252083 A JP 14252083A JP S6034905 A JPS6034905 A JP S6034905A
- Authority
- JP
- Japan
- Prior art keywords
- lung
- lactose
- active substance
- pharmaceutical preparation
- suspension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58142520A JPS6034905A (ja) | 1983-08-05 | 1983-08-05 | 肺表面活性物質製剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58142520A JPS6034905A (ja) | 1983-08-05 | 1983-08-05 | 肺表面活性物質製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6034905A true JPS6034905A (ja) | 1985-02-22 |
| JPH0160451B2 JPH0160451B2 (OSRAM) | 1989-12-22 |
Family
ID=15317264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58142520A Granted JPS6034905A (ja) | 1983-08-05 | 1983-08-05 | 肺表面活性物質製剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6034905A (OSRAM) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994000131A1 (fr) * | 1992-06-24 | 1994-01-06 | Tokyo Tanabe Company Limited | Agent prophylactique et agent curatif contre des maladies virales des voies respiratoires |
-
1983
- 1983-08-05 JP JP58142520A patent/JPS6034905A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994000131A1 (fr) * | 1992-06-24 | 1994-01-06 | Tokyo Tanabe Company Limited | Agent prophylactique et agent curatif contre des maladies virales des voies respiratoires |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0160451B2 (OSRAM) | 1989-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100231767B1 (ko) | 포말의 새로운 조성물, 그 중에서도 직장 포말, 그리고 이것으로 만들어진 포말 | |
| US6682747B1 (en) | Process for preparing an oral suspension of a pharmaceutical substance | |
| US4690823A (en) | Ibuprofen-containing soft gelatin capsules and process for preparing same | |
| CA2462606C (en) | Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer | |
| PT98272B (pt) | Processo para a preparacao de uma composicao farmaceutica para suspensao rapida em agua | |
| BG61752B1 (bg) | Аерозолни състави под налягане | |
| JPS59101423A (ja) | 新規なニフエジピン固形製剤 | |
| AU762464B2 (en) | Peroral active agent suspension | |
| JPS59205328A (ja) | 微粒子及び気泡を含有する超音波診断用造影剤及びその製法 | |
| US6121250A (en) | Lavage solution for intestinal tract | |
| RU2694530C2 (ru) | Способ изготовления жидких фармацевтических суспензий, содержащих висмут | |
| JP5144258B2 (ja) | 分子量に基づいて選択される少なくとも1種の魚ゼラチンを含む、急速分散剤形の製剤化方法 | |
| RU2084226C1 (ru) | Композиция, обладающая противоопухолевым действием | |
| JP2001114696A (ja) | 漢方ゼリー医薬組成物 | |
| JPS6034905A (ja) | 肺表面活性物質製剤 | |
| VenKateswaRlu et al. | Development and in-vitro Evaluation of Reconstitutable Suspension of Flucloxacillin | |
| KR100395864B1 (ko) | 트리메부틴을함유하는신규제약조성물및그제조방법 | |
| CN113694028A (zh) | 一种伏立康唑干混悬剂的制备方法 | |
| Blythe et al. | Evaluation of hydrophilic properties of bulk laxatives including the new agent, sodium carboxymethylcellulose | |
| JPH04265151A (ja) | リポソーム調製物 | |
| JPS59148718A (ja) | ユビデカレノン組成物 | |
| EP0468232A2 (en) | Suspending syrups | |
| PT1232746E (pt) | Composição farmacêutica que compreende goma xantana | |
| US20050136120A1 (en) | Intravenous pharmaceutical form of administration | |
| US20100221326A1 (en) | Pharmaceutical compositions for oral use for treating patients affected by obesity |